Dr. Albert Thomas Vitale, MD

Dr. Vitale practices at University of Utah Hospitals and Clinics - Unit in Salt Lake City, Utah.

Dr. Vitale's NPI, 1497832232, was assigned on November 1, 2006. Dr. Vitale graduated from New York Medical College in 1987. Dr. Vitale holds Utah license 5212942-1205.

Dr. Vitale's primary practice is University of Utah Hospitals and Clinics - Unit, at 50 North Medical Drive, Salt Lake City, UT 84132 in Salt Lake County. The practice phone is (801) 581-2337.

Dr. Vitale's primary practice is University of Utah Hospitals and Clinics - Unit in Salt Lake City, Utah. Dr. Vitale is also affiliated with University of Utah Hospital. The medical group on file is University of Utah Health. Dmand AI also links Dr. Vitale to 3 more group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Vitale practices, 5 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Vitale's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Vitale is licensed in Utah.

CMS data shows 1,107 Medicare services from Dr. Vitale across 8 procedure codes in 2024, for 160 Medicare patients. Medicare paid $48,512 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 160 Medicare patients who saw Dr. Vitale in 2024. The largest group is 75 to 84, with 62 patients. 66% of them have high blood pressure, and 60% have high cholesterol. 8% are also on Medicaid. Their average risk score is 1.35, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Vitale's median patient age at 72, with 65% women.

In 2024, Dr. Vitale wrote 87 Medicare Part D claims for 25 patients. 67% of them were for generic drugs. CMS names the drug for 28 of them, across 2 drugs with 11 or more claims each, at $1,193 in total drug cost. In 2023, CMS named 56 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 90 out of 100 for Dr. Vitale for performance year 2024, reported as part of a group. Dr. Vitale accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 35 papers to Dr. Vitale, published from 2015 to 2024. 2020 was the busiest year, with 8. The most frequent topics are Tomography, Optical Coherence, Visual Acuity and Uveitis. Dr. Vitale has published most often in Ocul Immunol Inflamm. Dr. Vitale's most frequent co-authors are Akbar Shakoor, MBBS, Jennifer Elizabeth Thorne, MD and Ivana K. Kim, MD.

CMS Open Payments shows 70 general payments to Dr. Vitale from 11 drug and device companies from 2016 to 2024. Consulting fees make up the largest share, 70% of the total. Genentech, Inc. paid the most, $18,060. It also lists 6 research payments totaling $346 from 2016 to 2019.

Dr. Vitale graduated from New York Medical College in 1987.